172 related articles for article (PubMed ID: 36595983)
21. A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer.
Gao C; Gao C; Yuan Q
Medicine (Baltimore); 2024 May; 103(21):e38027. PubMed ID: 38788043
[TBL] [Abstract][Full Text] [Related]
22. Herbal extract elemene intrathoracic injection in the treatment of lung cancer patients with malignant pleural effusion: a meta-anaylsis.
Chen J; Chen YJ; Wu MD
J Cancer Res Ther; 2014 Aug; 10 Suppl 1():56-9. PubMed ID: 25207893
[TBL] [Abstract][Full Text] [Related]
23. A meta-analysis of elemene versus DDP intrapleural injection in the treatment of malignant pleural effusion caused by lung cancer.
Wang X; Wang H; Li L
J Cancer Res Ther; 2016 Dec; 12(Supplement):C244-C247. PubMed ID: 28230027
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis.
Feng L; Wang Z; Jing L; Zhou Z; Shi S; Deng R; Liu Y; Meng Q
World J Surg Oncol; 2021 Feb; 19(1):64. PubMed ID: 33637113
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
26. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of paclitaxel-carboplatin alone or with endostar for advanced non-small cell lung cancer.
Han B; Xiu Q; Wang H; Shen J; Gu A; Luo Y; Bai C; Guo S; Liu W; Zhuang Z; Zhang Y; Zhao Y; Jiang L; Zhou J; Jin X
J Thorac Oncol; 2011 Jun; 6(6):1104-9. PubMed ID: 21532504
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of Endostar combined with platinum pleural infusion for malignant pleural effusion in tumor patients is significantly better than that of monotherapy, but the economy is lower: a systematic review, network meta-analysis and cost-effectiveness analysis.
Xia Y; Fang P; Zhang X; Su G; Shen A
Ann Transl Med; 2022 May; 10(10):604. PubMed ID: 35722417
[TBL] [Abstract][Full Text] [Related]
28. Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis.
Huang P; Guo ZK; Xue ZT
Medicine (Baltimore); 2023 Jul; 102(29):e34386. PubMed ID: 37478250
[TBL] [Abstract][Full Text] [Related]
29. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
30. [A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion].
Min S; Zheng Q; Zhang B; Yan D; Wang R; Qu Z; Li L; Liu J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):90-98. PubMed ID: 30827325
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
Chen X; Liu Y; Yin Y; Jin S; Ping G; Røe OD; Yan K; Shu Y; Guo R
J Chemother; 2012 Aug; 24(4):231-6. PubMed ID: 23040690
[TBL] [Abstract][Full Text] [Related]
33. Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion.
Massarelli E; Onn A; Marom EM; Alden CM; Liu DD; Tran HT; Mino B; Wistuba II; Faiz SA; Bashoura L; Eapen GA; Morice RC; Jack Lee J; Hong WK; Herbst RS; Jimenez CA
Clin Lung Cancer; 2014 Sep; 15(5):379-86. PubMed ID: 24913066
[TBL] [Abstract][Full Text] [Related]
34. Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Xu L; Wang B; Gao M; Zhang Y; Qi Q; Li T; Li C; Wang A; Li Y
Thorac Cancer; 2018 Aug; 9(8):950-955. PubMed ID: 29917319
[TBL] [Abstract][Full Text] [Related]
35. [A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
Han BH; Xiu QY; Wang HM; Shen J; Gu AQ; Luo Y; Bai CX; Guo SL; Liu WC; Zhuang ZX; Zhang Y; Zhao YZ; Jiang LY; Shi CL; Jin B; Zhou JY; Jin XQ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):854-9. PubMed ID: 22335953
[TBL] [Abstract][Full Text] [Related]
36. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
[TBL] [Abstract][Full Text] [Related]
37. Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
Jiang S; Wang G; Dong Y
Medicine (Baltimore); 2017 Dec; 96(51):e9077. PubMed ID: 29390436
[TBL] [Abstract][Full Text] [Related]
38. Assessment on the Efficacy and Safety of Aidi Injection Combined with Vinorelbine and Cisplatin for Treatment of Advanced Nonsmall Cell Lung Cancer.
Zhao HY; Zhou HY; Wang YT; Chen W; Qi SY; Cao JL; Li GH
Chin Med J (Engl); 2016 Mar; 129(6):723-30. PubMed ID: 26960377
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the therapeutic effects of pleural perfusion of NDP and cDDP in NSCLC patients with malignant pleural effusion].
Cong YY; Liu MY; Cai L
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):467-9. PubMed ID: 20819493
[TBL] [Abstract][Full Text] [Related]
40. Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer.
Yang WH; Xie J; Lai ZY; Yang MD; Zhang GH; Li Y; Mu JB; Xu J
Chin Med J (Engl); 2019 Apr; 132(8):922-927. PubMed ID: 30958433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
